A biotech stock with strong FDA approval odds this November may see limited upside amid a full valuation and a pending lawsuit.

The power of compounding and why saving regularly still works in today’s capital markets. How technology has transformed ...

The board is fielding shareholder demands for a clear plan to boost the bank’s stock price – and a strategy to compete ...

ASX-listed tech companies have released their latest quarterly results, showing solid progress across key areas.

MASAWARA Group founder and chief executive officer Shingai Mutasa has called for a new Zimbabwe’s financial infrastructure ...

Despite the Hurricanes’ rally, the Bruins stayed in command the rest of the game. They did not stray from their structure. Their forecheck arrived on time. They limited Carolina’s center-ice speed. In ...

Following its recently released half-year financials, the United Bank for Africa (UBA) Plc has announced its audited results ...

The BoJ also delivered largely as expected at its policy decision, where it held rates at 0.5 per cent. The recent ...

The Week in Breakingviews newsletter offers insights and ideas from Reuters' global financial commentary team. Sign up here.

Analysts say the Fed's pivot from quantitative tightening could propel Bitcoin to $200,000, citing key differences from 2019.

TradeWinds depends on being able to display ads on our services in order to finance our journalism.

The Federal Reserve’s latest decision – a modest 25-basis-point rate cut and the announcement that quantitative tightening ...